Combining imaging and pathway profiling: An alternative approach to cancer drug discovery

Drug Discovery Today

Volumn 17, Issue 5-6, 2012, Pages 203-214

  Carragher, Neil O ^a   Brunton, Valerie G ^a   Frame, Margaret C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LEUKOCYTE ELASTASE; QUANTUM DOT; SMALL INTERFERING RNA;

ADIPOCYTE; ANGIOGENESIS; APOPTOSIS; BIOLOGICAL MONITORING; BIOSAFETY; BIOSENSOR; BLEACHING; CANCER INVASION; CANCER RESEARCH; CANCER RESISTANCE; CANCER SCREENING; CARCINOGENESIS; CELL PROLIFERATION; COCULTURE; CYTOTOXICITY; DISEASE MODEL; DNA REPAIR; DRUG EFFICACY; DRUG RESEARCH; FLUORESCENCE RESONANCE ENERGY TRANSFER; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL PROTEOMICS; GENETIC ASSOCIATION; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HYDROPHOBICITY; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MACHINE LEARNING; MASS SPECTROMETRY; MEDICAL DECISION MAKING; MEMBRANE POTENTIAL; METASTASIS; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR PROBE; MUTATIONAL ANALYSIS; NANOANALYSIS; NANOTECHNOLOGY; NONHUMAN; PANCREAS CANCER; PHAGOCYTOSIS; PHARMACODYNAMICS; PHARMACOGENOMICS; PHENOTYPE; PHOTOACTIVATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; SYSTEMS BIOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; DIAGNOSTIC IMAGING; DRUG DISCOVERY; HUMANS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84857992908     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.02.002     Document Type: Review

References (51)

1. S.M. Paul How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 214
2. I. Kola, and J. Landis Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3 2004 711 715
3. E.C. Butcher Can cell systems biology rescue drug discovery? Nat. Rev. Drug Discov. 4 2005 461 467
4. F. Sams-Dodd Target-based drug discovery: is something wrong? Drug Discov. Today 10 2005 139 147
5. J.E. Dancey, and H.X. Chen Strategies for optimizing combinations of molecularly targeted anticancer agents Nat. Rev. Drug Discov. 5 2006 649 659
6. J.M. Stommel Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies Science 318 2007 287 290
7. Y. Chen Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors Clin. Cancer Res. 15 2009 3396 3405
8. A. Aleshin, and R.S. Finn SRC: a century of science brought to the clinic Neoplasia 12 2010 599 607
9. E.L. Mayer, and I.E. Krop Advances in targeting SRC in the treatment of breast cancer and other solid malignancies Clin. Cancer Res. 16 2010 3526 3532
10. S. Zhang Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways Nat. Med. 17 2011 461 469
11. M. Bickle The beautiful cell: high-content screening in drug discovery Anal. Bioanal. Chem. 398 2010 219 226
12. P. Alcock High content cell based primary screening for oncology targets - a perspective Eur. Pharm. Rev. 3 2010
13. M. Bickle High-content screening: a new primary screening tool? IDrugs 11 2008 822 826
14. P.D. Caie High-content phenotypic profiling of drug response signatures across distinct cancer cells Mol. Cancer Ther. 9 2010 1913 1926
15. Z.E. Perlman Multidimensional drug profiling by automated microscopy Science 306 2004 1194 1198
16. D.W. Young Integrating high-content screening and ligand-target prediction to identify mechanism of action Nat. Chem. Biol. 4 2008 59 68
17. H.H. Truong Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens Biomaterials 33 2012 181 188
18. N.O. Carragher Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover Clin. Exp. Metastasis 26 2009 381 397
19. B. Isherwood Live cell in vitro and in vivo imaging applications: accelerating drug discovery Pharmaceutics 3 2011 141 170
20. D.E. Nelson Oscillations in NF-kappaB signaling control the dynamics of gene expression Science 306 2004 704 708
21. P. Friedl Dynamic imaging of cancer invasion and metastasis: principles and preclinical applications Clin. Exp. Metastasis 26 2009 269 271
22. T.R. Jones Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning Proc. Natl. Acad. Sci. U. S. A. 106 2009 1826 1831
23. A.H. Beck Systematic analysis of breast cancer morphology uncovers stromal features associated with survival Sci. Transl. Med. 3 2011 108ra113
24. J. Pilling Development of a quantitative 96-well method to image glycogen storage in primary rat hepatocytes Mol. Cell. Biochem. 341 2010 73 78
25. A.B. Castoreno Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis Nat. Chem. Biol. 6 2010 457 463
26. O. Durr Robust hit identification by quality assurance and multivariate data analysis of a high-content, cell-based assay J. Biomol. Screen. 12 2007 1042 1049
27. I.G. Goldberg The Open Microscopy Environment (OME) Data Model and XML file: open tools for informatics and quantitative analysis in biological imaging Genome Biol. 6 2005 R47
28. K. Kozak Workflow-based software environment for large-scale biological experiments J. Biomol. Screen. 15 2010 892 899
29. E. Brown In vivo imaging of tumors Cold Spring Harb. Protoc. 2010 prot5452
30. A. Bullen Microscopic imaging techniques for drug discovery Nat. Rev. Drug Discov. 7 2008 54 67
31. J. Condeelis, and J.E. Segall Intravital imaging of cell movement in tumours Nat. Rev. Cancer 3 2003 921 930
32. E. Beerling Intravital microscopy: new insights into metastasis of tumors J. Cell Sci. 124 Pt 3 2011 299 310
33. M. Canel Use of photoactivation and photobleaching to monitor the dynamic regulation of E-cadherin at the plasma membrane Cell. Adh. Migr. 4 2010 491 501
34. M. Canel Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics Cancer Res. 70 2010 9413 9422
35. R. Frank, and R. Hargreaves Clinical biomarkers in drug discovery and development Nat. Rev. Drug Discov. 2 2003 566 580
36. R.B. Stoughton, and S.H. Friend How molecular profiling could revolutionize drug discovery Nat. Rev. Drug Discov. 4 2005 345 350
37. W. Kolch, and A. Pitt Functional proteomics to dissect tyrosine kinase signalling pathways in cancer Nat. Rev. Cancer 10 2010 618 629
38. H. Voshol Antibody-based proteomics: analysis of signaling networks using reverse protein arrays FEBS J. 276 2009 6871 6879
39. U. Weissenstein Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts Proteomics 6 2006 1427 1436
40. M.S. Carey Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy Clin. Cancer Res. 16 2010 2852 2860
41. R. Tibes Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells Mol. Cancer Ther. 5 2006 2512 2521
42. S. Iadevaia Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis Cancer Res. 70 2010 6704 6714
43. T. Grote Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer Proteomics 8 2008 3051 3060
44. B. Wilson Monitoring proteins and protein networks using reverse phase protein arrays Dis. Markers 28 2010 225 232
45. S. Ekins Pathway mapping tools for analysis of high content data Methods Mol. Biol. 356 2007 319 350
46. O. Kuchaiev GraphCrunch 2: software tool for network modeling, alignment and clustering BMC Bioinform. 12 2011 24
47. J. Lamb The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935
48. P. Shannon Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res. 13 2003 2498 2504
49. B.S. Hendriks Computational modelling of ErbB family phosphorylation dynamics in response to transforming growth factor alpha and heregulin indicates spatial compartmentation of phosphatase activity Syst. Biol. 153 2006 22 33
50. R.L. Ho, and C.A. Lieu Systems biology: an evolving approach in drug discovery and development Drugs R. D. 9 2008 203 216
51. E.J. Kunkel Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models Assay Drug Dev. Technol. 2 2004 431 441